Quality indicator | Numerator | Denominator | Percentage |
---|---|---|---|
Prevalence, incidence and mortality | |||
1. Patients with stage 3 or greater chronic kidney disease who have it documented in their cumulative patient profile* | 1856 | 6848 | 27.1 |
Screening, diagnosis & risk factors | |||
2. Percentage of patients with an initial eGFR < 60 mL/min per 1.73 m2 with an eGFR within 6 months* | 4068 | 8573 | 47.5 |
3. Percentage of patients with an initial† eGFR < 60 mL/min per 1.73 m2 with an ACR within 6 months* | 1400 | 8573 | 16.3 |
4. Percentage of patients with risk factors for chronic kidney disease (diabetes, hypertension) with an eGFR in the past 18 months | 23 998 | 32 637 | 73.5 |
5. Percentage of patients with risk factors for chronic kidney disease (diabetes, hypertension) with an ACR in the past 18 months | 9291 | 32 637 | 28.5 |
Management | |||
6. Percentage of patients with chronic kidney disease with an eGFR in the past 18 months | 6190 | 6848 | 90.4 |
7. Percentage of patients with chronic kidney disease with an ACR in the past 18 months | 2341 | 6848 | 34.2 |
8. Percentage of patients with chronic kidney disease with a BP recorded in the past 9 months | 5692 | 6848 | 83.1 |
9. Percentage of patients with diabetes and albuminuria (moderately or severely increased ACR ≥ 3 mg/mmol) with a BP recorded in the past 9 months | 5439 | 6320 | 86.1 |
10. Percentage of patients with chronic kidney disease with a most recent BP < 140/90 mm Hg, or with chronic kidney disease and diabetes with a most recent BP < 130/80 mm Hg | 4465 | 6848 | 65.2 |
11. Percentage of patients with diabetes and albuminuria (moderately or severely increased ACR ≥ 3 mg/mmol) who were prescribed an ACE inhibitor or ARB unless a contraindication or adverse effects are recorded | 3734 | 4997 | 74.7 |
12. Percentage of patients with chronic kidney disease who had a serum potassium test 7-30 days after initial ACE inhibitor-ARB prescription* | 2944 | 4965 | 59.3 |
13. Percentage of patients with chronic kidney disease with an ACE inhibitor and an ARB prescription on the same day* | 48 | 6848 | 0.7 |
14. Percentage of patients with chronic kidney disease and ≥ 1 prescription for NSAIDs* | 99 | 6848 | 1.4 |
15. Percentage of patients ≥ 50 years and ≤ 80 years of age with chronic kidney disease taking a statin unless contraindicated | 2236 | 3701 | 60.4 |
16. Percentage of patents with chronic kidney disease who received an influenza vaccine in the past year unless contraindicated | 4493 | 6848 | 65.6 |
Referral to a specialist | |||
17. Percentage of patients aged < 80 years with a referral to a nephrologist for eGFR < 30 mL/min per 1.73 m2 | 339 | 508 | 66.7 |
Note: ACE = angiotensin-converting enzyme, ACR = albumin-creatinine ratio, ARB = angiotensin II receptor blocker, BP = blood pressure, eGFR = estimated glomerular filtration rate, NSAID = nonsteroidal anti-inflammatory drug.
*Modified to be feasible to measure.
†First eGFR < 60 mL/min per 1.73 m2 at least 6 months before the load date of the electronic medical record.